A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology

Establishing an Evidence-Based Method to Diagnose Cardiac Sarcoidosis

“…Patients are receiving potentially toxic immunosuppression and implantable cardioverter defibrillators based on unnuanced FDG and CMR interpretations, respectively. The interpretive standards advocated by this report are consistent with recent imaging society guidelines 7,8 and are a wonderful clinical guide for interpretive readers.…”

Imaging cardiac sarcoidosis with FDG-PET: Take a look at the right side!

“…In patients with a suspicion of CS and arrhythmia on ECG, echocardiography is the first-line imaging tool to search for abnormalities in myocardial wall thickness or contraction. 7 However, echocardiography lacks sensitivity for the detection of subtle changes observed in CS and its findings are frequently non-specific. Cardiac MRI provides a higher sensitivity than echocardiography to assess the locations and extent of cardiac sarcoidosis.…”

Diagnosis and Therapy of Cardiac Sarcoidosis: A Clinical Perspective

“…Advanced cardiac imaging is suggested for patients with extracardiac sarcoidosis with symptoms of CHF, possible arrhythmia, along with an abnormal ECG and/echo. 18 Patients without known extracardiac sarcoidosis but with new unexplained CHF associated with conduction disturbances such as AV block, or ventricular arrhythmias, such as ventricular tachycardia, may also be candidates for advanced imaging.…”